Stryker Corporation
SYKNYSEHealthcare● Active
$305.66
+$4.45(+1.48%)
Market Cap$117.2B
P/E Ratio—
52W High$404.87
52W Low$281
Stryker Corporation (SYK) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
SYK · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 30, 2026EPS Actual
$2.60
Est. $2.98 · -12.8%
Revenue
$6.02B
Est. $6.34B · -5.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 30, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
SYK reports quarterly as a NYSE-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$-0.00
Rev. $0.01B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$-0.00
Rev. Est.$0.01B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 30, 2026 | $3.49 | — | — | — | $6.58B | — |
| ▼ Q2 FY2026 | Apr 30, 2026 | $2.98 | $2.60 | -12.8% | $6.02B | $6.34B | -5.0% |
| ▲ Q1 FY2026 | Jan 29, 2026 | $4.40 | $4.47 | +1.6% | $7.17B | $7.12B | +0.7% |
| ▲ Q4 FY2025 | Oct 30, 2025 | $3.13 | $3.19 | +1.9% | $6.06B | $6.04B | +0.2% |
| ▲ Q3 FY2025 | Jul 31, 2025 | $3.07 | $3.13 | +1.9% | $6.02B | $5.94B | +1.4% |
| ▲ Q2 FY2025 | May 1, 2025 | $2.71 | $2.84 | +4.8% | $5.87B | $5.69B | +3.1% |
| ▲ Q1 FY2025 | Jan 28, 2025 | $3.87 | $4.01 | +3.6% | $6.44B | $6.36B | +1.2% |
| ▲ Q4 FY2024 | Oct 29, 2024 | $2.77 | $2.87 | +3.6% | $5.49B | $5.37B | +2.3% |
Q3 FY2026
Jul 30, 2026
EPS Actual
—
EPS Est.
$3.49
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 30, 2026Miss
EPS Actual
$2.60
EPS Est.
$2.98
EPS Surpr.
-12.8%
Revenue
$6.02B
Q1 FY2026
Jan 29, 2026Beat
EPS Actual
$4.47
EPS Est.
$4.40
EPS Surpr.
+1.6%
Revenue
$7.17B
Q4 FY2025
Oct 30, 2025Beat
EPS Actual
$3.19
EPS Est.
$3.13
EPS Surpr.
+1.9%
Revenue
$6.06B
Q3 FY2025
Jul 31, 2025Beat
EPS Actual
$3.13
EPS Est.
$3.07
EPS Surpr.
+1.9%
Revenue
$6.02B
Q2 FY2025
May 1, 2025Beat
EPS Actual
$2.84
EPS Est.
$2.71
EPS Surpr.
+4.8%
Revenue
$5.87B
Q1 FY2025
Jan 28, 2025Beat
EPS Actual
$4.01
EPS Est.
$3.87
EPS Surpr.
+3.6%
Revenue
$6.44B
Q4 FY2024
Oct 29, 2024Beat
EPS Actual
$2.87
EPS Est.
$2.77
EPS Surpr.
+3.6%
Revenue
$5.49B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $6.08 | $6.19 | $6.34 | 15 |
| Q3 FY2028 | $4.34 | $4.42 | $4.53 | 8 |
| Q2 FY2028 | $4.30 | $4.38 | $4.48 | 8 |
| Q1 FY2028 | $3.67 | $3.74 | $3.83 | 11 |
| Q4 FY2027 | $5.35 | $5.45 | $5.58 | 14 |
| Q3 FY2027 | $3.99 | $4.06 | $4.16 | 7 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $9.0B | $9.2B | $9.3B | 6 |
| Q3 FY2028 | $7.6B | $7.7B | $7.8B | 6 |
| Q2 FY2028 | $7.5B | $7.6B | $7.7B | 6 |
| Q1 FY2028 | $6.9B | $7.0B | $7.1B | 6 |
| Q4 FY2027 | $8.4B | $8.6B | $8.7B | 7 |
| Q3 FY2027 | $7.1B | $7.2B | $7.4B | 7 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | Apr 30, 2026 | -12.8% | $315.13 | $315.13 | +0.00% |
| ▲ Q1 FY2026 | Jan 29, 2026 | +1.6% | $357.83 | $354.30 | -0.99% |
| ▲ Q4 FY2025 | Oct 30, 2025 | +1.9% | $369.59 | $368.98 | -0.17% |
| ▲ Q3 FY2025 | Jul 31, 2025 | +1.9% | $400.41 | $392.73 | -1.92% |
| ▲ Q2 FY2025 | May 1, 2025 | +4.8% | $373.92 | $373.99 | +0.02% |
| ▲ Q1 FY2025 | Jan 28, 2025 | +3.6% | $399.90 | $395.15 | -1.19% |
| ▲ Q4 FY2024 | Oct 29, 2024 | +3.6% | $356.01 | $359.01 | +0.84% |
| ▲ Q3 FY2024 | Jul 30, 2024 | +0.7% | $333.28 | $330.22 | -0.92% |
Q2 FY2026+0.00%
Report Date
Apr 30, 2026
EPS Beat/Miss
-12.8%
Price Before
$315.13
Price After
$315.13
Q1 FY2026-0.99%
Report Date
Jan 29, 2026
EPS Beat/Miss
+1.6%
Price Before
$357.83
Price After
$354.30
Q4 FY2025-0.17%
Report Date
Oct 30, 2025
EPS Beat/Miss
+1.9%
Price Before
$369.59
Price After
$368.98
Q3 FY2025-1.92%
Report Date
Jul 31, 2025
EPS Beat/Miss
+1.9%
Price Before
$400.41
Price After
$392.73
Q2 FY2025+0.02%
Report Date
May 1, 2025
EPS Beat/Miss
+4.8%
Price Before
$373.92
Price After
$373.99
Q1 FY2025-1.19%
Report Date
Jan 28, 2025
EPS Beat/Miss
+3.6%
Price Before
$399.90
Price After
$395.15
Q4 FY2024+0.84%
Report Date
Oct 29, 2024
EPS Beat/Miss
+3.6%
Price Before
$356.01
Price After
$359.01
Q3 FY2024-0.92%
Report Date
Jul 30, 2024
EPS Beat/Miss
+0.7%
Price Before
$333.28
Price After
$330.22
Avg Beat Reaction-0.62%
Avg Miss Reaction+0.00%
Beat Rate7 / 8 quarters
Largest Move-1.92% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: SYK ends December
Stryker Corporation (SYK) most recently reported earnings on April 30, 2026 for Q2 FY2026, posting EPS of $2.60 — missing the analyst consensus of $2.98 by -12.8%. The next SYK earnings date is expected around September 1, 2026.
Each quarter, investors track SYK earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. SYK revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
SYK's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
SYK earnings · 5 questionsStryker Corporation's next earnings report is expected around September 1, 2026. SYK typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; SYK historically reports after market close (AMC).
SYK earnings datewhen is SYK earningsSYK next earnings datewhen does SYK report earningsSYK earnings calendar
▸ Source: FMP · Stryker Corporation SEC filings · US GAAP · Stryker Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026